Go to SC301 Plastic Surgery AI Consultation Request
Sera AI Consultation
Sera AI Consultation
Go to SC301 Plastic Surgery AI Consultation Request
Skip to main content
301 blog

SC301 Clinic, Introducing Stem Cell Plastic Surgery, Attends Local Beauty Expo in China… Attracting Attention from Local Media Including CCTV

By 2019-06-27No Comments

Shin Dong-jin, Director of SC301 Clinic


SC301 Clinic (Chief Director Shin Dong-jin), which first introduced 'stem cell cosmetic surgery' medical technology in Korea in 2007, is participating in a local beauty expo in China and is actively pursuing the export of advanced stem cell medical technology to the Chinese market. 

 

 An official from SC301 Clinic stated, “We are currently participating in the 2019 Asia-Pacific Beauty & Health Expo (hereinafter the Asia-Pacific Beauty Expo), which is being held in Ningbo, Zhejiang Province, China, for three days from the 21st to the 23rd.” 

 

 The Asia-Pacific Beauty Expo is considered the second largest beauty and anti-aging trade fair in China, after the Shanghai Beauty Expo. 

 

 Thousands of industry professionals from both countries participate in the event, which is held alternately in Korea and China every year, seeking active exchanges in the beauty and anti-aging sectors between the two nations. It is reported that over 100 beauty companies representing Korea and China participated in this expo held in Ningbo, China. 

 

 SC301 Clinic announced plans to actively attract Chinese patients seeking more effective fat grafting procedures through local marketing at the expo, including breast and facial fat grafting using stem cells as well as anti-aging and pain treatments. Furthermore, the clinic intends to strengthen partnerships in the local stem cell beauty and anti-aging business to 본격화 (intensify) the export of stem cell medical technology to China.

  

 SC301 Clinic stated that as news of their participation in the expo spread in China, it is attracting significant attention from local beauty and anti-aging industry stakeholders, as well as the media and individual media outlets.

 

 On the morning of the first day of the expo alone, Rio Zhongpei, a representative Chinese "super influencer" with 2000 million subscribers, visited the booth and conducted a live on-site interview, and CCTV, China's leading state-run media, also filmed an introductory video for a documentary production at the booth.

 

 A hospital official stated, “Thanks to the organizers’ consideration, we were given the opportunity to give a presentation to hundreds of Chinese industry professionals representing the Korean beauty and anti-aging medical industry. We are pleased to see that the brand value of our hospital, which was the first in Korea to introduce stem cell plastic surgery, is being properly recognized at the exhibition. Taking this participation as an opportunity, we will actively engage in local marketing of Korea’s advanced stem cell medical technology in China.” 

 

 Kim Ji-in, the administrative director of SC301 Clinic who attended the expo leading a working group, announced that she was appointed as a judge for the 2019 Miss Intercontinental pageant, which is being held alongside the expo, at the request of the expo organizers.

 

 Shin Dong-jin, Representative Director of SC301 Clinic, stated, “Although stem cell breast and facial fat grafting are still unfamiliar concepts to Chinese people, recently, an increasing number of people in China are seeking natural-looking cosmetic procedures using stem cells and autologous fat rather than artificial materials such as implants or fillers.” He added, “In line with this changing trend, we will do our utmost to actively market the brand value of our clinic, which represents South Korea’s stem cell cosmetic surgery, anti-aging, and pain treatment, and to create a Korean Wave in stem cell cosmetic medicine.”

 

 Director Shin is known as the 'founder' who introduced stem cell plastic surgery techniques to the Korean market, including the country's first commercialization of stem cell breast augmentation in 2007.

http://www.siminilbo.co.kr/news/articleView.html?idxno=639937